Promoting Safety of Medicines for Children

Promoting Safety of Medicines for Children

This book will be of interest to all health care professionals, medicine regulatory authorities, pharmacovigilance centers, academia, the pharmaceutical industry and policy-makers.

Author: World Health Organization

Publisher: World Health Organization

ISBN: 9789241563437

Category: Medical

Page: 65

View: 491

Monitoring the safety of medicine use in children is of paramount importance since, during the clinical development of medicines, only limited data on this aspect are generated through clinical trials. Use of medicines outside the specifications described in the license (e.g. in terms of formulation, indications, contraindications or age) constitutes off-label and off-license use and these are a major area of concern. These guidelines are intended to improve awareness of medicine safety issues among everyone who has an interest in the safety of medicines in children and to provide guidance on effective systems for monitoring medicine safety in the pediatric populations. This book will be of interest to all health care professionals, medicine regulatory authorities, pharmacovigilance centers, academia, the pharmaceutical industry and policy-makers. Systems for monitoring medicine safety are described in Annex 1. Pharmacovigilance methods and some examples of recent information on adverse reactions to marketed medicines are discussed in Annex 2.--Publisher's description.
Categories: Medical

The Safety of Medicines

The Safety of Medicines

It is most opportune that Professor Folb has decided to review the present position in this monograph.

Author: P. I. Folb

Publisher: Springer

ISBN: UCAL:B4529156

Category: Medical

Page: 134

View: 292

The last thirty years have seen an unprecedented increase in the discovery of new drugs, and moreover, these drugs, unlike many of the nostra of former times, have varied and powerful pharmacological actions. The occurrence of one or two "drug disasters", together with a change in public attitudes, has made it necessary for governments to introduce legislation to control the intro duction and release of new therapeutic agents, and most countries in the Western World have some form of drug licensing agency. Whole series of regulations have appeared which aim at discovering and defining the toxicity of new drugs. Many of these regulations rely heavily on testing drugs in animals before they are used in man, and at present very extensive and prolonged animal studies are required by most licensing authorities. It is most opportune that Professor Folb has decided to review the present position in this monograph. It is not only inhumane but also wasteful of time and money if extensive animal experiments which have little or no relevance to the human situation are carried out; furthermore, such results may even be dangerously misleading. There is little doubt that some preliminary animal investigations are necessary, but it is essential to keep their relevance under continuous review and to adopt a critical and flexible approach rather than heap regulation upon regulation.
Categories: Medical

Drug Safety Data

Drug Safety Data

The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for premarketing risk assessment.

Author: Michael J. Klepper

Publisher: Jones & Bartlett Learning

ISBN: 0763769126

Category: Medical

Page: 312

View: 840

Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk was selected for The First Clinical Research Bookshelf - Essential reading for clinical research professionals by the Journal of Clinical Research Best Practices. Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk provides drug safety/pharmacovogilance professionals, pharmaceutical and clinical research scientists, statisticians, programmers, medical writers, and technicians with an accessible, practical framework for the analysis, summary and interpretation of drug safety data. The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for pre- and post-marketing risk assessment. With decades of pharmaceutical research and drug safety expertise, authors Dr. Klepper and Dr. Cobert discuss how quality planning, safety training, and data standardization result in significant cost, time, and resource savings. Through illustrative, step-by-step instruction, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is the definitive guide to drug safety data analysis and reporting. Key features include: * Step-by-step instruction on how to analyze, summarize and interpret safety data for mandatory governmental safety reports * Pragmatic tips...and mistakes to avoid * Simple explanations of what safety data are collected, and what the data mean * Practical approaches to determining a drug effect and understanding its clinical significance * Guidance for determining risk throughout the lifecycle of a drug, biologic or nutraceutical * Examples of user-friendly data displays that enhance safety signal identification * Ways to improve data quality and reduce the time, resources and costs involved in mandatory safety reporting * Relevant material for the required training of drug safety/pharmacovigilance professionals * SPECIAL FEATURE: Actual examples of an Integrated Analysis of Safety (IAS) -used in the preparation of the Integrated Summary of Safety (ISS) and the Summary of Clinical Safety (SCS) reports -, and the Periodic Safety Update Report (PSUR)
Categories: Medical

Medication Safety

Medication Safety

Medication safety is the most challenging goal for pharmacy practice and patient safety professionals in all health care facilities.

Author: Henri Richard Manasse

Publisher: ASHP

ISBN: 9781585280896

Category: Medical

Page: 394

View: 980

Medication safety is the most challenging goal for pharmacy practice and patient safety professionals in all health care facilities.
Categories: Medical

Sessional Papers

Sessional Papers

the new Committee on Safety of Medicines, recommended that it should reflect a similar range of skills, and that a number of members of the Committee on Safety of Drugs, including the Chairman, Professor E. F. Scowen, should be included ...

Author: Great Britain. Parliament. House of Commons

Publisher:

ISBN: MINN:31951D02550647W

Category: Great Britain

Page:

View: 560

Categories: Great Britain

Power and Dependence

Power and Dependence

Author: Charles Medawar

Publisher:

ISBN: UCAL:B4526764

Category: Consumer education

Page: 354

View: 398

Categories: Consumer education

Cobert s Manual of Drug Safety and Pharmacovigilance

Cobert s Manual of Drug Safety and Pharmacovigilance

Completely revised and updated, the Manual of Drug Safety and Pharmacovigilance, Second Edition is a how-to manual for those working in the fields of drug safety, clinical research, pharmacology, regulatory affairs, government and legal ...

Author: Barton Cobert

Publisher: Jones & Bartlett Publishers

ISBN: 9780763791599

Category: Medical

Page: 433

View: 744

Completely revised and updated, the Manual of Drug Safety and Pharmacovigilance, Second Edition is a how-to manual for those working in the fields of drug safety, clinical research, pharmacology, regulatory affairs, government and legal professions. This comprehensive and practical guide discusses the theory and the practicalities of drug safety (also known as pharmacovigilance) and side effects, as well as providing essential information on drug safety and regulations, including: recognizing, monitoring, reporting and cataloging serious adverse drug reactions. The Manual of Drug Safety and Pharmacovigilance, Second Edition teaches the ins and outs of drug safety in the industry, hospitals, FDA, and other health agencies both in the US and around the world, and presents critical information about what is done when confronted with a drug safety problem.
Categories: Medical

Pharmaceutical Medicine

Pharmaceutical Medicine

Pharmacovigilance activities include: • Collecting and managing data on the safety of medicines. • Reviewing data to detect new or changing safety issues (signals). • Assessing and evaluating safety data in order to make safety ...

Author: Adrian Kilcoyne

Publisher: OUP Oxford

ISBN: 9780191510397

Category: Medical

Page: 480

View: 681

The breadth of the pharmaceutical medicine can be daunting, but this book is designed to navigate a path through the speciality. Providing a broad overview of all topics relevant to the discipline of pharmaceutical medicine, it gives you the facts fast, in a user-friendly format, without having to dive through page upon page of dense text. With 136 chapters spread across 8 sections, the text offers a thorough grounding in issues ranging from medicines regulation to clinical trial design and data management. This makes it a useful revision aid for exams as well as giving you a taster of areas of pharmaceutical medicine adjacent to your current role. For healthcare professionals already working in the field, this book offers a guiding hand in difficult situations as well as supplying rapid access to the latest recommendations and guidelines. Written by authors with experience in the industry and drug regulation, this comprehensive and authoritative guide provides a shoulder to lean on throughout your pharmaceutical career.
Categories: Medical

Stephens Detection and Evaluation of Adverse Drug Reactions

Stephens  Detection and Evaluation of Adverse Drug Reactions

Praise for previous editions "This book presents a comprehensive and wide-ranging overview of the science of pharmacovigilance.

Author: John Talbot

Publisher: John Wiley & Sons

ISBN: 9780470986349

Category: Medical

Page: 751

View: 634

Written with practitioners in mind, this new edition of Stephen’s Detection of Adverse Drug Reactions: Principle and Practice continues to be one of the corner stones of the pharmaceutical medicine list. The classic text covers the issues and problems involved in the detection of adverse drug reactions (ADRs) throughout the life cycle of a medicine from animal studies through to clinical trials, its introduction to the market, followed by wide clinical use, and eventual decline in use or withdrawal. The sixth edition is completely revised and updated including five new chapters on pharmacogenomics, ADRs with herbal medicines, safety of medical devices, safety issues with oncology drugs, and economic aspects of ADRs. All tables and web information needed in order to practice are included to make this sixth edition a complete primer for the new practitioner and a reference for the more experienced.
Categories: Medical